Home
Finance
Companies
Industry
Market

Telomir Pharmaceuticals Inc

why Telomir Pharmaceuticals Inc [TELO] is a Good Choice for Investors After New Price Target of $15.50

October 7, 2025

Misty Lee

Telomir Pharmaceuticals Inc [NASDAQ: TELO] jumped around 0.02 points on Monday, while shares priced at $1.42 at the close of ...

most recent

Market

why BlackBerry Ltd [BB] is a Good Choice for Investors After New Price Target of $5.06

Industry

Novo Nordisk ADR [NVO] Stock trading around $59.65 per share: What’s Next?

Finance

Bit Origin Ltd [BTOG] is -76.30% lower this YTD. Is it still time to buy?

Companies

Kraft Heinz Co [KHC] Revenue clocked in at $25.31 billion, down -26.48% YTD: What’s Next?

Market

Gap, Inc [GAP] moved down -0.37: Why It’s Important

Industry

why Telomir Pharmaceuticals Inc [TELO] is a Good Choice for Investors After New Price Target of $15.50

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled